Detalhe da pesquisa
1.
Measurable residual disease detected by flow cytometry independently predicts prognoses of NPM1-mutated acute myeloid leukemia.
Ann Hematol
; 102(2): 337-347, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36378304
2.
Impact of a novel prognostic model on allogeneic hematopoietic stem cell transplantation outcomes in patients with CMML.
Am J Hematol
; 98(9): 1394-1406, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37366294
3.
Shikonin exerts an anti-leukemia effect against FLT3-ITD mutated acute myeloid leukemia cells via targeting FLT3 tyrosine kinase and its downstream pathways.
Acta Haematol
; 2023 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926079
4.
Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study.
Haematologica
; 107(12): 2918-2927, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35615930
5.
Basiliximab for steroid-refractory acute graft-versus-host disease: A real-world analysis.
Am J Hematol
; 97(4): 458-469, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064928
6.
Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study.
Br J Haematol
; 175(2): 265-274, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27352174
7.
Association of IL-6 polymorphisms with hepatocellular carcinoma risk: evidences from a meta-analysis.
Tumour Biol
; 35(4): 3551-61, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24318992
8.
The surface molecular signature of leukemic cells is associated with NPM1 mutations and FLT3 -ITD in patients with de novo acute myeloid leukemia.
Acta Haematol
; 131(3): 148-52, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24192815
9.
Identification of the HLA-A*11:463 allele in a Chinese patient and his father.
HLA
; 103(3): e15442, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38488733
10.
Identification of the novel HLA-C*01:02:86 allele in a Chinese individual.
HLA
; 102(1): 89-90, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951755
11.
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study.
Blood Adv
; 7(16): 4349-4357, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078706
12.
A global study for acute myeloid leukemia with RARG rearrangement.
Blood Adv
; 7(13): 2972-2982, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799929
13.
Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions.
Front Oncol
; 12: 806137, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35178345
14.
Identification of the novel HLA-A*02:981 allele by sequencing-based typing.
HLA
; 100(2): 142-143, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384353
15.
Recognization of the HLA-A*24:516 allele in a Chinese patient and his daughter.
HLA
; 100(2): 151-153, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384358
16.
Sequence-based typing identification of the novel allele HLA-B*40:482.
HLA
; 100(3): 270-271, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35478491
17.
Detection of an HLA-C*01 variant, HLA-C*01:212, in a Chinese individual.
HLA
; 100(3): 275-277, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524576
18.
Identification of the novel allele HLA-B*13:157 by sequence-based typing.
HLA
; 100(3): 265-266, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524579
19.
A novel HLA-C allele, HLA-C*15:244.
HLA
; 100(3): 283-284, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524580
20.
Characterization of the novel allele HLA-B*35:251:02.
HLA
; 100(3): 268-270, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524588